TRAZODONE NO FURTHER A MYSTERY

Avoid coadministration with sensitive CYP3A substrates. If coadministration unavoidable, observe for adverse reactions and decrease CYP3A substrate dose in accordance with products labeling.  The believed track record danger of important delivery defects and miscarriage for that indicated populace is unidentified. All pregnancies have a history th